FMI - Friedrich Miescher Institute
home contact directory secure login
extranet
 
 
About the FMI
Research
Technical resources
Licensing
News
Seminars
Graduate studies
Teaching
Open positions
Links
   
 
 
© FMI Basel, Switzerland
 
 
LICENSING OPPORTUNITIES  
FMI up go back   previous back/next next
Title (priority date): Use of tenascin-w as a biomarker for colon cancer (22.10.2007)
Reference: 52297
Inventors: Chiquet & Degen
Description: This patent application relates to the surprising findings that there is a significant correlation between the levels of tenascin-W in the peripheral blodd and the presence of colon cancer in patients.
Applications: Diagnostics. Blood screening.
Status: Pneding PCT
Opportunity: Exclusive or non exclusive license
Publications: Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Degen M, Brellier F, Schenk S, Driscoll R, Zaman K, Stupp R, Tornillo L, Terracciano L, Chiquet-Ehrismann R, Rüegg C, Seelentag W.. Int J Cancer. 2008 Jun 1;122(11):2454-61
Contact: Dr. Nicolas Favre, tel: +41 61 6978382, e-mail: nicolas.favre@fmi.ch
PCT File: WO2009/053354